|1.||Muttukrishna, Shanthi: 2 articles (01/2009 - 12/2002)|
|2.||Bersinger, Nick A: 2 articles (01/2004 - 12/2002)|
|3.||Schittny, J C: 1 article (01/2014)|
|4.||Gerber, S: 1 article (01/2014)|
|5.||Reymondin, D: 1 article (01/2014)|
|6.||Damnon, F: 1 article (01/2014)|
|7.||Braissant, O: 1 article (01/2014)|
|8.||Gremlich, S: 1 article (01/2014)|
|9.||Roth-Kleiner, M: 1 article (01/2014)|
|10.||Baud, D: 1 article (01/2014)|
01/01/1987 - "In vitro and in vivo studies of the production of placental proteins (HCG, SP1, PPs) in human choriocarcinoma cell lines."
06/01/1988 - "Molar extravillous trophoblasts were clearly distinguishable from choriocarcinoma cells in terms of their morphology and the location of placental proteins. "
06/01/1988 - "We therefore observed the morphology of trophoblastic cells which do not constitute a villous structure, including choriocarcinoma cells, and analyzed the location of placental proteins in these cells immunohistochemically. "
01/01/1987 - "These results indicate that placental proteins are not equally produced in heterogeneous choriocarcinoma cells."
01/01/1987 - "These placental proteins showed positive staining in portions of choriocarcinoma cells. "
01/01/2011 - "The purpose of this study was to identify the placental proteins that are associated with preeclampsia by performing proteomic analysis. "
11/01/2011 - "As the abnormal placental proteins develop weeks before clinical preeclampsia, early application of external negative abdominal pressure may prevent development of the syndrome."
01/01/2004 - "Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies."
12/01/2002 - "Pregnancy-associated and placental proteins in the placental tissue of normal pregnant women and patients with pre-eclampsia at term."
01/01/1989 - "Placental proteins 12 and 14 in pre-eclampsia."
01/01/1990 - "None of the placental proteins are useful for screening, as prognostic indicators, or for evaluating the effects of therapy in groups of patients with nontrophoblastic neoplasms. "
01/01/1990 - "Among the three placental proteins discussed, HCG is the only clinically useful tumor marker, and the value of HCG measurements is restricted to patients with gestational and nongestational trophoblastic disease. "
06/15/1989 - "Five tumors, including the two with trophoblastic differentiation, contained the three placental proteins. "
06/15/1989 - "Placental proteins in high-grade urothelial neoplasms. "
01/01/1987 - "Placental proteins (PP 5, PP 12 and PP 14) in ovarian tumors. "
|4.||Hydatidiform Mole (Molar Pregnancy)
07/01/1996 - "Little is known about the control of the production of these two placental proteins in molar pregnancies. "
04/01/1994 - "Expression of placental proteins in complete and partial hydatidiform moles."
01/01/1983 - "Among the number of newly isolated placental proteins, PP5 and PP12 share some common characteristics: Both are present in the syncytiotrophoblast of normal placenta and hydatidiform mole, but less frequently, if at all, in choriocarcinoma. "
05/01/1983 - "Circulating levels of four specific placental proteins, human chorionic gonadotrophin (hCG), Schwangerschafts protein 1 (SP1), placental protein 5 (PP5) and pregnancy-associated plasma protein A (PAPP-A), were measured in 31 patients with hydatidiform mole before treatment. "
05/15/2002 - "Since specific assays are now available for inhibin A, inhibin B, and activin A, the current study evaluated whether and which of these placental proteins is increased in presence of a molar pregnancy. "
02/01/1983 - "It is concluded that these placental proteins are of no clinical use in the management of ovarian carcinoma patients."
09/01/1973 - "Lung carcinoma associated with production of three placental proteins. "
06/01/1982 - "An indirect immunoperoxidase method has been used to study a series of breast carcinomas for the presence of five potential biological markers (two appropriate to breast, two placental proteins and one oncofetal protein). "
07/01/1977 - "Placental proteins and their subunits as tumor markers in prostatic carcinoma."
07/01/1977 - "A retrospective evaluation of serum bank specimens from 47 patients with prostatic carcinoma revealed no elevation of the placental proteins hPL, hCG-beta, and hCG-alpha. "
|1.||Chorionic Gonadotropin (Human Chorionic Gonadotropin)
|2.||Pregnancy-Specific beta 1-Glycoproteins
|3.||Placental Lactogen (Human Placental Lactogen)
|4.||Proteins (Proteins, Gene)
|8.||Biological Markers (Surrogate Marker)
|9.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)